Mapping epitope characteristics on carcinoembryonic antigen
- PMID: 2425837
- PMCID: PMC2001645
- DOI: 10.1038/bjc.1986.154
Mapping epitope characteristics on carcinoembryonic antigen
Abstract
A method of epitope analysis is described in which the binding of one monoclonal antibody (MAb) to radiolabeled carcinoembryonic antigen (CEA) competes with the subsequent binding of an immobilised second MAb. From the degree of blocking obtained, we have identified both structurally related and independent epitopes on CEA. Using this technique to study fifteen MAbs, we have been able to recognise at least 6 unrelated epitopes of the CEA glycoprotein. Further characterisation of these epitopes was accomplished by means of immunohistochemistry. Of the fifteen MAbs, 6 were specific for CEA and reacted with at least 3 unrelated regions of the glycoprotein. Of the remaining 9 MAbs, 2 cross-reacted with erythrocytes, 5 with components of liver and 7 with polymorphonuclear neutrophils. Cross-reactions with liver were varied showing differential antibody specificity for bile canaliculi, Kupffer cells and bile duct epithelium. A high degree of correlation between epitope relatedness and immunohistochemical specificity was found. Two CEA-specific and 4 cross-reactive MAbs were also shown to react with ion-sensitive sites on the CEA glycoprotein.
Similar articles
-
Monoclonal antibodies to carcinoembryonic antigen: a systematic analysis of antibody specificities by using related normal antigens and evidence for allotypic determinants on carcinoembryonic antigen.J Immunol. 1984 Oct;133(4):2090-7. J Immunol. 1984. PMID: 6206151
-
Monoclonal antibodies for carcinoembryonic antigen and related antigens as a model system: a systematic approach for the determination of epitope specificities of monoclonal antibodies.J Immunol. 1983 May;130(5):2308-15. J Immunol. 1983. PMID: 6187849
-
Immunological heterogeneity of carcinoembryonic antigen: immunohistochemical detection of carcinoembryonic antigen determinants in colonic tumors with monoclonal antibodies.Cancer Res. 1983 Feb;43(2):693-701. Cancer Res. 1983. PMID: 6184153
-
Carcinoembryonic antigen: a rat model.Immunol Invest. 1989 Jan-May;18(1-4):143-57. doi: 10.3109/08820138909112234. Immunol Invest. 1989. PMID: 2471689 Review.
-
Introduction to the CEA family: structure, function and secretion.Int J Biol Markers. 1992 Jul-Sep;7(3):132-6. doi: 10.1177/172460089200700302. Int J Biol Markers. 1992. PMID: 1431334 Review.
Cited by
-
Factors influencing variability of localisation of antibodies to carcinoembryonic antigen (CEA) in patients with colorectal carcinoma--implications for radioimmunotherapy.Br J Cancer. 1992 Jun;65(6):825-31. doi: 10.1038/bjc.1992.176. Br J Cancer. 1992. PMID: 1616854 Free PMC article.
-
Disposition of the prodrug 4-(bis (2-chloroethyl) amino) benzoyl-L-glutamic acid and its active parent drug in mice.Br J Cancer. 1990 Dec;62(6):909-14. doi: 10.1038/bjc.1990.407. Br J Cancer. 1990. PMID: 2257218 Free PMC article.
-
Radioimmunotherapy of metastatic colorectal tumours with iodine-131-labelled antibody to carcinoembryonic antigen: phase I/II study with comparative biodistribution of intact and F(ab')2 antibodies.Br J Cancer. 1994 Sep;70(3):521-5. doi: 10.1038/bjc.1994.338. Br J Cancer. 1994. PMID: 8080740 Free PMC article. Clinical Trial.
-
Comparison of anti-fetal colonic microvillus and anti-CEA antibodies in peroperative radioimmunolocalisation of colorectal cancer.Br J Cancer. 1990 Jun;61(6):891-4. doi: 10.1038/bjc.1990.199. Br J Cancer. 1990. PMID: 2372492 Free PMC article.
-
Radioimmunoluminography: a tool for relating tissue antigen concentration to clinical outcome.Br J Cancer. 1999 May;80(5-6):922-6. doi: 10.1038/sj.bjc.6690443. Br J Cancer. 1999. PMID: 10360677 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources